Sanstar Commissions Expanded Starch Capacity at Dhule
Sanstar Limited has commissioned its expanded native starch manufacturing capacity at the Dhule facility, raising total installed capacity from 1,100 TPD to 2,350 TPD. The project, fully funded by Rs. 1,816 million in IPO proceeds, includes a derivatives facility set for commissioning in FY2026-27. The expansion enhances operational efficiencies and strengthens the company's position in the maize-based specialty products industry.

*this image is generated using AI for illustrative purposes only.
Sanstar Limited announced on 12th May 2026 the commissioning of its expanded native starch manufacturing capacity at its Dhule facility in Maharashtra. This development marks a significant milestone in the company's growth journey and is part of its broader capacity expansion plan funded through IPO proceeds. The entire amount of Rs. 1,816 million allocated towards the Dhule expansion has now been fully utilised.
Capacity Expansion at a Glance
With this commissioning, Sanstar has increased its total installed capacity from 1,100 TPD to 2,350 TPD, positioning itself to become one of the largest manufacturers in India's maize-based specialty products industry. The following table summarises the manufacturing footprint across Sanstar's facilities:
| Facility | Capacity | Process |
|---|---|---|
| Kutch, Gujarat | 350 TPD | Wet Milling Process |
| Dhule, Maharashtra (1) | 750 TPD | Wet Milling Process |
| Dhule, Maharashtra (2) | 1,250 TPD | Wet Milling Process |
| Total | 2,350 TPD |
The expansion is being implemented in two phases. While the native starch capacity has now been commissioned, the derivatives facility at Dhule is expected to be commissioned within FY2026-27.
Strategic Significance and Product Portfolio
The Dhule facility is strategically located near key maize-growing regions and major ports, providing strong logistical advantages and supporting efficient sourcing and export operations. The expanded capacity is expected to improve operational efficiencies, enhance scale benefits, and strengthen the company's ability to cater to growing domestic and international demand.
Sanstar's diverse product portfolio spans multiple categories:
- Native Starch Products
- Modified Starch Products: Yellow Dextrin, Oxidized Starch, White Dextrin, Cationic Starch, Pregel Starch
- Derivatives Products: Meltodextrin Powder, Liquid Glucose, Liquid Dextrose, Dextrose Monohydrate, Dextrose Anhydrous, Dried Glucose Solids
- Co-Products: Gluten, Fiber, Maize Steep Liquor, Enriched Protein, Germ
Based on FY25 revenues, the segment breakdown was approximately food/personal care at ~45%, animal nutrition at ~25%, and industrials/others at ~30%.
Management Commentary
Commenting on the development, Mr. Gouthamchand Chowdhary, Chairman and Managing Director, stated: "The commissioning of our expanded native starch capacity at Dhule marks an important milestone in Sanstar's growth journey. This expansion strengthens our manufacturing capabilities and enhances our ability to serve a diverse and growing customer base across industries."
He further noted that despite originally planning for a 1,000 MTPD expansion at the time of the IPO, the company has successfully scaled its installed crushing capacity to 1,250 MTPD, demonstrating strong execution capability and operational efficiency. "With the full utilization of IPO proceeds towards this project, we are now well positioned to scale our operations. The upcoming commissioning of the derivatives facility will further enhance our product portfolio, enabling us to move towards higher value-added offerings," he added.
Historical Stock Returns for Sanstar
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.36% | +8.74% | +21.57% | +14.96% | +17.67% | -4.96% |
How will Sanstar's doubling of capacity to 2,350 TPD impact its market share relative to competitors in India's maize-based specialty products industry?
What is the expected timeline and capital requirement for commissioning the derivatives facility at Dhule, and how will it be funded given IPO proceeds are fully utilized?
Will the expanded capacity drive Sanstar to increase its export revenue mix, and which international markets are likely to be prioritized?


































